HOSPITALIZED TYPE 1 DIABETES PATIENTS (T1D) WITH COVID-19, WITH AND WITHOUT DIABETIC KETOACIDOSIS (DKA) HAD SIMILAR OUTCOMES USING AN ELECTRONIC GLYCEMIC MANAGEMENT SYTSTEM (EGMS)